MOVE · Corvex Inc. Common Stock
View on chartInsiders & Stakes
| Emily Fairbairn Director | ▼ Sell | Other | 1,214,513 Shares held | 7/7/2026 | View profile |
| John Adler Crystal III Chief Executive Officer | ▼ Sell | Other | 711,321 Shares held | 7/7/2026 | View profile |
| Christopher Moreland CFO | ▲ Buy | Grant | 523,211 Shares held | 7/1/2026 | View profile |
| Brian Cullinan Director | ▲ Buy | Grant | 111,276 Shares held | 7/1/2026 | View profile |
| Patrick Fleury Chief Financial Officer | ▲ Buy | Grant | 100,000 Shares held | 7/1/2026 | View profile |
| Jeremy Cogan CFO | ▲ Buy | Grant | 97,504 Shares held | 3/18/2026 | View profile |
| John Mastrototaro Chief Executive Officer | ▼ Sell | Open Market | 56,114 Shares held | 1/27/2026 | View profile |
| Nicholas M. Donofrio Director | ▲ Buy | Grant | 50,000 Shares held | 7/1/2026 | View profile |
| Ruben Caballero Director | ▲ Buy | Option Exercise | 38,017 Shares held | 6/25/2026 | View profile |
| Seth Demsey | ▼ Sell | Other | 31,409 Shares held | 7/7/2026 | View profile |
| Michael Aaron Leabman Chief Technology Officer | ▼ Sell | Open Market | 22,639 Shares held | 1/14/2026 | View profile |
| Shaheen Wirk | ▲ Buy | Option Exercise | 15,960 Shares held | 3/13/2026 | View profile |
| Forte Nan Kirsten Director | ▲ Buy | Open Market | 7,142 Shares held | 1/27/2023 | View profile |
Transaction History
| Seth Demsey | ▼ Sell | Other | 5,484,388 | $0 | 7/7/2026 |
| Seth Demsey | ▼ Sell | Other | 31,270 | $0 | 7/7/2026 |
| John Adler Crystal III | ▼ Sell | Other | 3,345,523 | $0 | 7/7/2026 |
| John Adler Crystal III | ▼ Sell | Other | 708,154 | $0 | 7/7/2026 |
| Emily Fairbairn | ▼ Sell | Other | 1,205,282 | $0 | 7/7/2026 |
| Emily Fairbairn | ▲ Buy | Grant | 135,800 | $0 | 7/1/2026 |
| Christopher Moreland | ▲ Buy | Grant | 523,211 | $0 | 7/1/2026 |
| Patrick Fleury | ▲ Buy | Grant | 100,000 | $0 | 7/1/2026 |
| Nicholas M. Donofrio | ▲ Buy | Grant | 50,000 | $0 | 7/1/2026 |
| Brian Cullinan | ▲ Buy | Grant | 50,000 | $0 | 7/1/2026 |
| Brian Cullinan | ▲ Buy | Option Exercise | 48,209 | $44K | 6/30/2026 |
| Ruben Caballero | ▲ Buy | Option Exercise | 29,197 | $27K | 6/25/2026 |
| Seth Demsey | ▼ Sell | Other | 24,532 | $0 | 3/31/2026 |
| Seth Demsey | ▼ Sell | Other | 139 | $0 | 3/31/2026 |
| John Adler Crystal III | ▼ Sell | Other | 14,965 | $0 | 3/31/2026 |
| John Adler Crystal III | ▼ Sell | Other | 3,167 | $0 | 3/31/2026 |
| Emily Fairbairn | ▼ Sell | Other | 9,231 | $0 | 3/31/2026 |
| Jeremy Cogan | ▲ Buy | Grant | 37,000 | $0 | 3/18/2026 |
| Emily Fairbairn | ▲ Buy | Option Exercise | 55,250 | $69K | 3/16/2026 |
| Shaheen Wirk | ▲ Buy | Option Exercise | 10,000 | $13K | 3/13/2026 |
| John Mastrototaro | ▼ Sell | Open Market | 5,746 | $125K | 1/27/2026 |
| John Mastrototaro | ▼ Sell | Open Market | 2,407 | $56K | 1/27/2026 |
| Jeremy Cogan | ▼ Sell | Open Market | 3,288 | $63K | 1/27/2026 |
| Jeremy Cogan | ▼ Sell | Open Market | 4,622 | $93K | 1/27/2026 |
| Jeremy Cogan | ▼ Sell | Open Market | 5,548 | $121K | 1/27/2026 |
| Jeremy Cogan | ▼ Sell | Open Market | 2,099 | $49K | 1/27/2026 |
| John Mastrototaro | ▼ Sell | Open Market | 14,960 | $310K | 1/27/2026 |
| Jeremy Cogan | ▼ Sell | Open Market | 13,179 | $272K | 1/27/2026 |
| John Mastrototaro | ▼ Sell | Open Market | 4,512 | $86K | 1/27/2026 |
| John Mastrototaro | ▼ Sell | Open Market | 5,444 | $110K | 1/27/2026 |
| Jeremy Cogan | ▲ Buy | Option Exercise | 64,834 | $81K | 1/26/2026 |
| John Mastrototaro | ▲ Buy | Option Exercise | 72,834 | $91K | 1/26/2026 |
| Michael Aaron Leabman | ▼ Sell | Open Market | 6,845 | $46K | 1/14/2026 |
| Michael Aaron Leabman | ▼ Sell | Open Market | 2,076 | $14K | 1/13/2026 |
| Michael Aaron Leabman | ▼ Sell | Open Market | 3,377 | $24K | 1/12/2026 |
| Michael Aaron Leabman | ▲ Buy | Grant | 11,174 | $0 | 1/9/2026 |
| John Mastrototaro | ▲ Buy | Grant | 11,919 | $0 | 1/9/2026 |
| Brian Cullinan | ▲ Buy | Grant | 4,768 | $0 | 1/9/2026 |
| Ruben Caballero | ▲ Buy | Grant | 2,980 | $0 | 1/9/2026 |
| Ruben Caballero | ▲ Buy | Grant | 2,980 | $0 | 1/9/2026 |
| Brian Cullinan | ▲ Buy | Grant | 2,980 | $0 | 1/9/2026 |
| Emily Fairbairn | ▲ Buy | Grant | 4,470 | $0 | 1/9/2026 |
| Emily Fairbairn | ▲ Buy | Grant | 5,959 | $0 | 1/9/2026 |
| Shaheen Wirk | ▲ Buy | Grant | 2,980 | $0 | 1/9/2026 |
| Shaheen Wirk | ▲ Buy | Grant | 2,980 | $0 | 1/9/2026 |
| Michael Aaron Leabman | ▼ Sell | Open Market | 783 | $6K | 1/9/2026 |
| Jeremy Cogan | ▲ Buy | Grant | 9,299 | $0 | 1/9/2026 |
| Michael Aaron Leabman | ▼ Sell | Open Market | 3,593 | $26K | 1/8/2026 |
| Michael Aaron Leabman | ▼ Sell | Open Market | 3,293 | $24K | 1/7/2026 |
| Michael Aaron Leabman | ▲ Buy | Option Exercise | 42,250 | $53K | 1/6/2026 |
| Jeremy Cogan | ▼ Sell | Open Market | 3,859 | $31K | 1/6/2026 |
| Jeremy Cogan | ▼ Sell | Open Market | 4,359 | $33K | 1/6/2026 |
| Jeremy Cogan | ▲ Buy | Option Exercise | 20,000 | $25K | 1/5/2026 |
| Jeremy Cogan | ▼ Sell | Open Market | 1,879 | $16K | 1/5/2026 |
| John Mastrototaro | ▲ Buy | Option Exercise | 5,000 | $6K | 1/5/2026 |
| John Mastrototaro | ▼ Sell | Open Market | 2,514 | $21K | 1/5/2026 |
| Shaheen Wirk | ▼ Sell | Other | 6,841 | $0 | 11/3/2025 |
| Michael Aaron Leabman | ▼ Sell | Other | 21,260 | $0 | 11/3/2025 |
| Brian Cullinan | ▼ Sell | Other | 13,271 | $0 | 11/3/2025 |
| Jeremy Cogan | ▼ Sell | Other | 31,871 | $0 | 11/3/2025 |
| Emily Fairbairn | ▼ Sell | Other | 12,442 | $0 | 11/3/2025 |
| Ruben Caballero | ▼ Sell | Other | 8,295 | $0 | 11/3/2025 |
| John Mastrototaro | ▼ Sell | Other | 39,226 | $0 | 11/3/2025 |
| Emily Fairbairn | ▲ Buy | Grant | 31,028 | $0 | 10/3/2025 |
| Shaheen Wirk | ▲ Buy | Grant | 20,685 | $0 | 10/3/2025 |
| Brian Cullinan | ▲ Buy | Grant | 33,096 | $0 | 10/3/2025 |
| Ruben Caballero | ▲ Buy | Grant | 20,685 | $0 | 10/3/2025 |
| Jeremy Cogan | ▲ Buy | Grant | 134,456 | $0 | 10/3/2025 |
| John Mastrototaro | ▲ Buy | Grant | 165,484 | $0 | 10/3/2025 |
| John Mastrototaro | ▲ Buy | Grant | 149,257 | $0 | 7/3/2025 |
| Emily Fairbairn | ▲ Buy | Grant | 27,985 | $0 | 7/3/2025 |
| Michael Aaron Leabman | ▲ Buy | Grant | 139,925 | $0 | 7/3/2025 |
| Ruben Caballero | ▲ Buy | Grant | 18,657 | $0 | 7/3/2025 |
| Brian Cullinan | ▲ Buy | Grant | 29,851 | $0 | 7/3/2025 |
| Jeremy Cogan | ▲ Buy | Grant | 121,272 | $0 | 7/3/2025 |
| Shaheen Wirk | ▲ Buy | Grant | 18,657 | $0 | 7/3/2025 |
| Ruben Caballero | ▲ Buy | Grant | 43,605 | $0 | 5/9/2025 |
| John Mastrototaro | ▲ Buy | Grant | 77,521 | $0 | 5/9/2025 |
| Jeremy Cogan | ▲ Buy | Grant | 62,986 | $0 | 5/9/2025 |
| Brian Cullinan | ▲ Buy | Grant | 69,767 | $0 | 5/9/2025 |
| Michael Aaron Leabman | ▲ Buy | Grant | 72,674 | $0 | 5/9/2025 |
| Emily Fairbairn | ▲ Buy | Grant | 65,407 | $0 | 5/9/2025 |
| Shaheen Wirk | ▲ Buy | Grant | 29,070 | $0 | 5/9/2025 |
| Ruben Caballero | ▲ Buy | Open Market | 22,000 | — | 4/2/2024 |
| Jeremy Cogan | ▲ Buy | Open Market | 45,000 | — | 4/2/2024 |
| Brian Cullinan | ▲ Buy | Open Market | 44,000 | — | 4/2/2024 |
| Emily Fairbairn | ▲ Buy | Open Market | 4,690,000 | — | 4/2/2024 |
| John Mastrototaro | ▲ Buy | Open Market | 176,500 | — | 4/2/2024 |
| John Mastrototaro | ▲ Buy | Open Market | 12,000 | $10K | 11/14/2023 |
| Jeremy Cogan | ▲ Buy | Open Market | 12,000 | $10K | 11/14/2023 |
| Emily Fairbairn | ▲ Buy | Open Market | 295,000 | $251K | 11/14/2023 |
| Jeremy Cogan | ▲ Buy | Open Market | 35,000 | $35K | 6/13/2023 |
| Michael Aaron Leabman | ▲ Buy | Open Market | 25,000 | $25K | 6/13/2023 |
| John Mastrototaro | ▲ Buy | Open Market | 20,000 | $20K | 6/13/2023 |
| Emily Fairbairn | ▲ Buy | Open Market | 250,000 | $250K | 6/13/2023 |
| Brian Cullinan | ▲ Buy | Open Market | 10,000 | $10K | 6/13/2023 |
| Ruben Caballero | ▲ Buy | Open Market | 18,200 | $26K | 2/15/2023 |
| Forte Nan Kirsten | ▲ Buy | Open Market | 7,142 | — | 1/27/2023 |
| Brian Cullinan | ▲ Buy | Open Market | 7,142 | — | 1/27/2023 |
| Jeremy Cogan | ▲ Buy | Open Market | 17,857 | — | 1/27/2023 |
| Michael Aaron Leabman | ▲ Buy | Open Market | 17,857 | — | 1/27/2023 |
| John Mastrototaro | ▲ Buy | Open Market | 7,142 | — | 1/27/2023 |
| Emily Fairbairn | ▲ Buy | Open Market | 178,571 | — | 1/27/2023 |
| John Mastrototaro | ▲ Buy | Option Exercise | 10,000 | $5K | 5/12/2022 |
| Emily Fairbairn | ▲ Buy | Open Market | 3,011 | $9K | 4/1/2022 |
| Emily Fairbairn | ▲ Buy | Open Market | 5,000 | $14K | 3/31/2022 |
| Emily Fairbairn | ▲ Buy | Open Market | 5,000 | $19K | 11/23/2021 |
| Michael Aaron Leabman | ▲ Buy | Open Market | 7,000 | $28K | 11/22/2021 |
| Michael Aaron Leabman | ▲ Buy | Open Market | 2,100 | $8K | 11/19/2021 |
| John Mastrototaro | ▲ Buy | Open Market | 3,000 | $11K | 11/19/2021 |
| Emily Fairbairn | ▲ Buy | Open Market | 1,000 | $4K | 11/18/2021 |
| Emily Fairbairn | ▲ Buy | Open Market | 4,000 | $16K | 11/18/2021 |
| John Mastrototaro | ▲ Buy | Open Market | 1,500 | $6K | 11/18/2021 |
| John Mastrototaro | ▲ Buy | Open Market | 1,500 | $6K | 11/18/2021 |
| Jeremy Cogan | ▲ Buy | Grant | 3,000 | $11K | 11/17/2021 |
| Michael Aaron Leabman | ▲ Buy | Open Market | 1,500 | $5K | 11/16/2021 |
| Jeremy Cogan | ▲ Buy | Grant | 9,000 | $31K | 11/16/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Corvex files prospectus for share resale and seeks Whitbread board seat
Corvex has filed a prospectus to register the resale of up to 4,258,068 common shares on behalf of selling stockholders. At the same time, an activist linked to Corvex is pursuing a board seat at Whitbread, citing concerns over the company's strategy. The share resale filing could increase the number of shares available in the market, while the activist effort highlights the firm's involvement in governance matters beyond its own operations.
Corvex files prospectus for share resale and seeks Whitbread board seat. Corvex has filed a prospectus to register the resale of up to 4,258,068 common shares on behalf of selling stockholders. At the same time, an activist linked to Corvex is pursuing a board seat at Whitbread, citing concerns over the company's strategy. The share resale filing could increase the number of shares available in the market, while the activist effort highlights the firm's involvement in governance matters beyond its own operations.